Who owns MAINZ BIOMED N V?
- Ticker: QUCY
- CUSIP Number: n5436l119
Tip: Access positions for across all investors
Analyze quarterly positions in Mainz Biomed N V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mainz Biomed N V stock
Who bought or sold MAINZ BIOMED N V this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 87k | $41k | 60% | Mar 2026 |
|
| Steward Partners Investment Advisory | 30k | $14k | 0% | Mar 2026 |
|
| Jane Street | 16k | $7.6k | -13% | Mar 2026 |
|
| Harbour Investments | 16k | $7.5k | 100% | Mar 2026 |
|
| Journey Advisory Group | 15k | $7.1k | 0% | Mar 2026 |
|
| Two Sigma Securities | 13k | $6.1k | -3% | Mar 2026 |
|
| Virtu Financial | 13k | $14k | 100% | Dec 2025 |
|
| SBI Securities | 12k | $5.5k | 3353% | Mar 2026 |
|
| Advisor Group Holdings | 2.1k | $2.4k | 0% | Dec 2025 |
|
| Provenance Wealth Advisors | 1.2k | $555.054000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 600.00 | $283.980000 | 100% | Mar 2026 |
|
| Newbridge Financial Services Group | 500.00 | $237.000000 | 0% | Mar 2026 |
|
| HighMark Wealth Management | 200.00 | $94.000000 | 0% | Mar 2026 |
|
| Morgan Stanley | 189.00 | $90.001800 | 0% | Mar 2026 |
|
| IFP Advisors | 90.00 | $43.002000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $0 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Mainz Biomed N V?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2025 | 395k | $588k |
| HPM Partners | Dec 2025 | 163k | $183k |
| Dauntless Investment Group | Sep 2025 | 51k | $76k |
| CI Private Wealth | Dec 2025 | 20k | $22k |
| Citadel Advisors | Dec 2025 | 13k | $14k |